Back

Prospective evaluation of transcatheter aortic valve implantation (TAVI) with coronary alignment and impact on coronary access

1 September 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: TAVI and beyond Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Christopher pavitt

University Hospitals Sussex, Brighton (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Implementing a novel selection criteria and pathway for same-day discharge after TAVI
Doctor R. Sethi (Uxbridge, GB)
Abstract Slides Video
Presentation thumbnail
Permanent pacemaker implantation is associated with an increased risk of heart failure hospitalization in transcatheter aortic valve implantation patients with reduced systolic function
Doctor K. Hu (Wuerzburg, DE)
Abstract Slides Video
Presentation thumbnail
Correlation of prosthesis position on mid-term pacing burden in patients with new permanent pacemaker after TAVI
Doctor P. Breitbart (Frankfurt am Main, DE)
Abstract Slides Video
Presentation thumbnail
Comparison of mortality scores performance in transcatheter aortic valve replacement: suiting up to percutaneous intervention.
Doctor A. Martins (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Cusp-overlap technique to reduce permanent pacemaker implantation rate after transcatheter aortic valve implantation
Doctor M. Abrantes De Figueiredo (Lisboa, PT)
Abstract Slides Video

Access the full session

Session thumbnail
TAVI and beyond

The Event

Event poster

ESC Congress 2024

1 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Assessment of commissural and coronary ostial alignment of aortic valve bioprosthesis after transcatheter aortic valve implantation
thumbnail
Congress Presentation
Aortic stenosis with concomitant coronary artery disease: strategies to access the coronary arteries
thumbnail
Congress Presentation
Patient-based strategies: valve choice and technical issues

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources